Indeed, melitracen is reported to have imipramine and amitriptyline-like effects and efficacy against depression and anxiety, though with improved tolerability and a somewhat faster onset of action.
Melitracen has been found to exhibit antidepressant and anxiolytic properties similar to imipramine and amitriptyline, but it is associated with better tolerance and faster symptom relief.